Evaluation of accuracy of FAD-GDH- and mutant Q-GDH-based blood glucose monitors in multi-patient populations.

BACKGROUND Glucose dehydrogenases have been highly promoted to high-accuracy blood glucose (BG) monitors. The flavin adenine dinucleotide glucose dehydrogenase (FAD-GDH) and mutant variant of quinoprotein glucose dehydrogenase (Mut. Q-GDH) are widely used in high-performance BG monitors for multi-patient use. Therefore we conducted accuracy evaluation of the GDH monitors, FAD-GDH-based GM700 and Mut. Q-GDH-based Performa. METHODS Different patients were enrolled: patients with and without diabetes, patients receiving respiratory therapies, hemodialysis (HD) and peritoneal dialysis (PD) patients, and neonates. The accuracy evaluation of FAD-GDH- and Mut. Q-GDH-based monitors referred to ISO 15197:2013 which applies new criteria for the minion accuracy requirements: more than 95% of the blood glucose readings shall fall within ±15mg/dL of the reference method at glucose concentration <100mg/dL and within ±15% of the reference method at glucose concentration ≥100mg/dL. Bland-Altman plots were used to evaluate the 2 GDH monitors as well. RESULTS Bland-Altman plots visualized excellent precision of the BG monitors. The 95% limit agreement of overall results for the FAD-GDH-based monitors was within ±12% and that for the Mut. Q-GDH-based monitors was from -10 to +17%. Both BG monitors met the accuracy requirements of ISO 15197:2013. The FAD-GDH-based monitor performed better with neonates and patients with and without diabetes, and the Mut. Q-GDH-based monitor performed better with HD and PD patients. CONCLUSIONS Analytical results prove that the GDH-based monitors tolerate a broad BG concentration range, are oxygen independent, have BG specificity, and have minimal interference from hematocrit. The GDH-based monitors are reliable for multi-patient use.

[1]  Kenji Kano,et al.  Novel FAD-Dependent Glucose Dehydrogenase for a Dioxygen-Insensitive Glucose Biosensor , 2006, Bioscience, biotechnology, and biochemistry.

[2]  Muhammad Nadeem Zafar,et al.  Characterization of different FAD-dependent glucose dehydrogenases for possible use in glucose-based biosensors and biofuel cells , 2012, Analytical and Bioanalytical Chemistry.

[3]  L. Heinemann,et al.  Accuracy in Blood Glucose Measurement: What Will a Tightening of Requirements Yield? , 2012, Journal of diabetes science and technology.

[4]  D. Benaron,et al.  Neonatal Hypoglycemia, Part I: Background and Definition , 1997, Clinical pediatrics.

[5]  Darrell M. Wilson,et al.  Consensus Report of the Coalition for Clinical Research—Self-Monitoring of Blood Glucose , 2008, Journal of diabetes science and technology.

[6]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[7]  Marco Cardosi,et al.  Amperometric Glucose Sensors for Whole Blood Measurement Based on Dehydrogenase Enzymes , 2012 .

[8]  A. D. Jeffrey,et al.  Evaluation of the Impact of Hematocrit and Other Interference on the Accuracy of Hospital-Based Glucose Meters , 2008 .

[9]  L. C. Clark,et al.  ELECTRODE SYSTEMS FOR CONTINUOUS MONITORING IN CARDIOVASCULAR SURGERY , 1962 .

[10]  A. Turner,et al.  Glucose oxidase: an ideal enzyme , 1992 .

[11]  Koji Sode,et al.  A Disposable Electrochemical Glucose Sensor Using Catalytic Subunit of Novel Thermostable Glucose Dehydrogenase , 2007 .

[12]  G J Kost,et al.  Oxygen effects on glucose meter measurements with glucose dehydrogenase- and oxidase-based test strips for point-of-care testing , 2001, Critical care medicine.

[13]  J. Nichols.  What is accuracy and how close must the agreement be? , 2005, Diabetes technology & therapeutics.

[14]  J. Ellison,et al.  Review of Adverse Events Associated With False Glucose Readings Measured by GDH-PQQ–Based Glucose Test Strips in the Presence of Interfering Sugars , 2010, Diabetes Care.

[15]  Ming-Hsun Wu,et al.  Accuracy and precision evaluation of seven self-monitoring blood glucose systems. , 2011, Diabetes technology & therapeutics.

[16]  G. H. Thorpe,et al.  Assessing the quality of publications evaluating the accuracy of blood glucose monitoring systems. , 2013, Diabetes technology & therapeutics.

[17]  W Janssen,et al.  Positive interference of icodextrin metabolites in some enzymatic glucose methods. , 1998, Clinical chemistry.

[18]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[19]  J. Mahoney,et al.  Assessing the quality of glucose monitor studies: a critical evaluation of published reports. , 2007, Clinical chemistry.

[20]  G J Kost,et al.  Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. , 2009, Archives of pathology & laboratory medicine.

[21]  H. Yoshida,et al.  Construction and characterization of mutant water-soluble PQQ glucose dehydrogenases with altered K(m) values--site-directed mutagenesis studies on the putative active site. , 1999, Biochemical and biophysical research communications.

[22]  Ming-Shih Lee,et al.  Assessing the quality of Bionime self-monitoring blood glucose system Rightest GM110: a critical evaluation of interference and ambient circumstances. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[23]  D. Adamkin,et al.  Postnatal Glucose Homeostasis in Late-Preterm and Term Infants , 2011, Pediatrics.

[24]  T. Hirokawa,et al.  Engineering PQQ glucose dehydrogenase with improved substrate specificity. Site-directed mutagenesis studies on the active center of PQQ glucose dehydrogenase. , 2004, Biomolecular engineering.

[25]  K. Sode,et al.  Review of Glucose Oxidases and Glucose Dehydrogenases: A Bird's Eye View of Glucose Sensing Enzymes , 2011, Journal of diabetes science and technology.

[26]  M. W. Ward Platt,et al.  The investigation and management of neonatal hypoglycaemia. , 2005, Seminars in fetal & neonatal medicine.

[27]  J. Mahoney,et al.  Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management , 2007, Diabetes Care.

[28]  Christina Schmid,et al.  System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose according to DIN EN ISO 15197 , 2012, Journal of diabetes science and technology.

[29]  Christina Schmid,et al.  Lot-to-Lot Variability of Test Strips and Accuracy Assessment of Systems for Self-Monitoring of Blood Glucose according to ISO 15197 , 2012, Journal of diabetes science and technology.

[30]  John M Ellison,et al.  Assessing glucose monitor performance--a standardized approach. , 2007, Diabetes technology & therapeutics.

[31]  Xiao Dong Chen,et al.  Glucose oxidase: natural occurrence, function, properties and industrial applications , 2008, Applied Microbiology and Biotechnology.

[32]  Guido Freckmann,et al.  System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. , 2010, Diabetes technology & therapeutics.

[33]  K. Aziz,et al.  Screening guidelines for newborns at risk for low blood glucose. , 2004, Paediatrics & child health.

[34]  Joseph Wang,et al.  Glucose Biosensors: 40 Years of Advances and Challenges , 2001 .